為什麼 2026 年是生物技術行業的復甦之年
該行業的逆風正在消散。這對尋求流動性的風險投資公司以及希望尋找增長故事的股市來説都是好消息，Nilesh Kumar 在一篇客座評論中寫道
Headwinds in the sector are clearing. That is good news for venture firms seeking liquidity and for a stock market looking for growth stories, Nilesh Kumar writes in a guest commentary.